Anti-CD20-mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives. [electronic resource]
- Kidney international 05 2020
- 885-893 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1523-1755
10.1016/j.kint.2019.12.025 doi
Antibodies, Monoclonal--therapeutic use Antigens, CD20 Autoimmune Diseases--therapy B-Lymphocytes Humans Lupus Erythematosus, Systemic Lymphocyte Depletion Rituximab--therapeutic use